Přihlásit se Zaregistrujte se zdarma

Hrubá marže společnosti Albireo Pharma Inc

Jaká je hodnota metriky Hrubá marže společnosti Albireo Pharma Inc?

Hodnota metriky Hrubá marže společnosti Albireo Pharma Inc je 95.56%

Jaká je definice metriky Hrubá marže?



Hrubá marže (Gross margin) je rozdíl mezi příjmy a náklady na prodané zboží dělený příjmy a vyjádřený v procentech.

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Hrubá marže společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Albireo Pharma Inc

Čemu se věnuje společnost Albireo Pharma Inc?

Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.

Firmy s metrikou hrubá marže podobnou společnosti Albireo Pharma Inc